Rare diseases
Investigational molecules
Locations
50 Rue Richer, 75009 Paris, France
Research activity in Crohn’s disease includes treatment strategies aimed at transmural response and deeper control of intestinal inflammation, with attention to endoscopic healing and disease activity in the small and large bowel.
The sponsor also supports work in patients with moderate to severe Crohn’s disease, reflecting a focus on active disease requiring advanced therapeutic management.
Groupe D'etude Therapeutique Des Affections Inflammatoires Du Tube Digestif runs clinical trials in conditions such as Crohn's disease, Colitis ulcerative, among others.
Clinical trials run by this sponsor – those enrolling participants first.
One-Year Effectiveness Study of Guselkumab in Adults with Crohn’s Disease
FranceA study testing how well mirikizumab works to achieve transmural healing in patients with Crohn's Disease
FranceStudy Comparing Standard Care and Targeted Treatment with Telemonitoring for Ulcerative Colitis Patients Using Adalimumab
FranceStudy on Managing Moderate Postoperative Recurrence in Crohn's Disease with Infliximab for Patients After Ileocolonic Surgery
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
